Cybin (HELP) Shares Outstanding (2020 - 2026)
Cybin's (HELP) quarterly Shares Outstanding (Entity) came in at $5.2 million in Q1 2026, up 72.1% YoY from $3.0 million in Q1 2025, and up 17.04% on a QoQ basis from $4.5 million in Q4 2025.
Cybin (HELP) Shares Outstanding (2020 - 2026) Analysis & Trends
Cybin (HELP) has 7 years of Shares Outstanding (Entity) data on file, last reported at $5.2 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 72.1% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (up 72.1% YoY) and the FY2026 annual result came in at $5.2 million, up 72.1% from the prior year.
- Shares Outstanding (Entity) improved to $5.2 million in Q1 2026, from $4.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $5.2 million in Q1 2026 to a low of $659922.0 in Q1 2022.
- A 5-year average of $2.2 million and a median of $1.3 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) rose 9.08% — and 2024, when it soared 268.68%.
- Tracing HELP's Shares Outstanding (Entity) over 5 years: stood at $745131.0 in 2022, then jumped by 76.66% to $1.3 million in 2023, then surged by 127.74% to $3.0 million in 2024, then jumped by 48.67% to $4.5 million in 2025, then rose by 17.04% to $5.2 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $5.2 million (Q1 2026), $4.5 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | 34.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.80 Mn |
| Dec 31, 2025 | 29.74 Mn |
| Sep 30, 2025 | 23.31 Mn |
| Jun 30, 2025 | 22.40 Mn |
| Mar 31, 2025 | 20.22 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 20.00 Mn |
| Jun 30, 2024 | 20.00 Mn |
| Mar 31, 2024 | 8.30 Mn |
| Dec 31, 2023 | 8.78 Mn |
| Sep 30, 2023 | 6.17 Mn |
| Jun 30, 2023 | 5.43 Mn |
| Feb 28, 2023 | 8.46 Mn |
| Dec 31, 2022 | 4.97 Mn |
| Sep 30, 2022 | 4.76 Mn |
| May 31, 2022 | 8.42 Mn |
| Mar 31, 2022 | 4.40 Mn |
| Feb 28, 2022 | 4.52 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Sep 30, 2021 | 4.36 Mn |